Biogen Inc.

10/19/2021 | Press release | Distributed by Public on 10/19/2021 04:31

Sage Therapeutics and Biogen Announce Plans to Submit a New Drug Application (NDA) for Zuranolone to the U.S. Food & Drug Administration in the Second Half of 2022 with Rolling[...]